Search

Your search keyword '"Li, Bob"' showing total 737 results

Search Constraints

Start Over You searched for: Author "Li, Bob" Remove constraint Author: "Li, Bob"
737 results on '"Li, Bob"'

Search Results

1. Automated real-world data integration improves cancer outcome prediction

3. DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism

4. Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

8. Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

9. Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

10. ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

12. Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study

13. Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

14. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

18. A tailored approach to horizon scanning for cancer medicines

19. KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

20. Genomic mapping of metastatic organotropism in lung adenocarcinoma

22. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

23. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

24. Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations

28. Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

29. Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers

30. Inferring gene expression from cell-free DNA fragmentation profiles

31. Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

32. Sotorasib versus pembrolizumab in combination with platinum doublet chemotherapy as first-line treatment for metastatic or locally advanced, PD-L1 negative, KRAS G12C-mutated NSCLC (CodeBreaK 202).

33. Patient-reported experience with an immunotherapy telehealth platform.

35. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

38. Case report: dynamic personalized physiological monitoring in lung cancer using wearable data.

40. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

41. Remote Monitoring and Data Collection for Decentralized Clinical Trials

42. Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer

43. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

44. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

45. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

46. Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors

47. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

48. Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non–Small-Cell Lung Cancer in the United States

49. Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

50. Optimal Systemic Treatment and Real-World Clinical Application of Ctdna in Patients with Metastatic Her2-Mutant Lung Cancer

Catalog

Books, media, physical & digital resources